BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18363761)

  • 1. IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a patient with linear IgA disease.
    Ishii N; Ohyama B; Yamaguchi Z; Hashimoto T
    Br J Dermatol; 2008 May; 158(5):1151-3. PubMed ID: 18363761
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune responses in patients with linear IgA bullous dermatosis: both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.
    Lin MS; Fu CL; Olague-Marchan M; Hacker MK; Zillikens D; Giudice GJ; Fairley JA
    Clin Immunol; 2002 Mar; 102(3):310-9. PubMed ID: 11890718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of childhood bullous pemphigoid.
    Toyama T; Nakamura K; Kuramochi A; Ohyama B; Hashimoto T; Tsuchida T
    Eur J Dermatol; 2009; 19(4):368-71. PubMed ID: 19451055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180.
    Tashima S; Konishi K; Koga H; Hashimoto T
    Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415
    [No Abstract]   [Full Text] [Related]  

  • 10. Linear IgA disease: clinical presentation, diagnosis, and pathogenesis.
    Venning VA
    Immunol Allergy Clin North Am; 2012 May; 32(2):245-53, vi. PubMed ID: 22560137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of psoriasis and linear IgA disease in a patient with recent herpes zoster infection.
    Cooke N; Jenkinson H; Wojnarowska F; McKenna K; Alderdice J
    Clin Exp Dermatol; 2005 Nov; 30(6):643-5. PubMed ID: 16197377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.
    Hayashi I; Shinkuma S; Shimizu S; Natsuga K; Ujiie H; Yasui C; Tsuchiya K; Nishie W; Shimizu H
    Br J Dermatol; 2012 May; 166(5):1116-20. PubMed ID: 22182184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
    Desai N; Allen J; Ali I; Venning V; Wojnarowska F
    Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
    Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
    Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Izumi R; Fujimoto M; Yazawa N; Nakashima H; Asashima N; Watanabe R; Kuwano Y; Kurokawa M; Hashimoto T; Tamaki K
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S94-7. PubMed ID: 17434049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of linear IgA disease in a child with IgA and IgG circulating antibodies directed to BPAg2.
    Viglizzo G; Cozzani E; Nozza P; Occella C; Parodi A
    Int J Dermatol; 2007 Dec; 46(12):1302-4. PubMed ID: 18173529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
    Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
    Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brunsting-Perry cicatricial pemphigoid associated with autoantibodies to the C-terminal domain of BP180.
    Daito J; Katoh N; Asai J; Ueda E; Takenaka H; Ishii N; Hashimoto T; Kishimoto S
    Br J Dermatol; 2008 Sep; 159(4):984-6. PubMed ID: 18637895
    [No Abstract]   [Full Text] [Related]  

  • 19. Pemphigoid gestationis with IgG autoantibodies to both the 120 kDa LAD-1 and the BP180 NC16a domain.
    Takayama N; Nakazono S; Kumagai J; Chiorean R; Sitaru C; Ishii N; Hashimoto T; Namiki T
    Eur J Dermatol; 2015 Apr; 25(2):190-2. PubMed ID: 25547184
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of lichen planus pemphigoides with autoantibodies to the NC16a and C-terminal domains of BP180 and to desmoglein-1.
    Sekiya A; Kodera M; Yamaoka T; Iwata Y; Usuda T; Ohzono A; Yasukochi A; Koga H; Ishii N; Hashimoto T
    Br J Dermatol; 2014 Nov; 171(5):1230-5. PubMed ID: 24813536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.